Skip to main content
Top
Published in: Respiratory Research 1/2013

Open Access 01-12-2013 | Review

The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis

Author: Riitta Kaarteenaho

Published in: Respiratory Research | Issue 1/2013

Login to get access

Abstract

A new international statement defines usual interstitial pneumonia (UIP) which is a histological and radiological form of idiopathic pulmonary fibrosis (IPF) more precisely than previously. In the diagnosis of IPF, either in high resolution computed tomography (HRCT) a UIP pattern must be present or alternatively specific combinations of HRCT and surgical lung biopsy findings can be accepted. In about two third of the cases IPF can be diagnosed by clinical and radiological criteria. Thus surgical lung biopsy is needed in about one third of cases to achieve the ultimate diagnosis, which requires multidisciplinary cooperation. In large clinical trials conducted during the last decade, lung biopsy was performed in about 30–60% of the cases. The most serious complication of lung biopsy is mortality within 30 days after the procedure, with a frequency of about 3–4% reported in most studies. Because of the histological variability, surgical lung biopsy should be taken from a minimum of two lobes. The number of fibroblast foci in surgical lung biopsy has been shown to correlate with survival in several studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183: 788-824. 10.1164/rccm.2009-040GL.PubMedCrossRef Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011, 183: 788-824. 10.1164/rccm.2009-040GL.PubMedCrossRef
2.
go back to reference Fishbein MC: Diagnosis: to biopsy or not to biopsy: assessing the role of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis. Chest. 2005, 128: 520S-525S. 10.1378/chest.128.5_suppl_1.520S.PubMedCrossRef Fishbein MC: Diagnosis: to biopsy or not to biopsy: assessing the role of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis. Chest. 2005, 128: 520S-525S. 10.1378/chest.128.5_suppl_1.520S.PubMedCrossRef
3.
go back to reference Glaspole IN, Wells AU, du Bois RM: Lung biopsy in diffuse parenchymal lung disease. Monaldi Arch Chest Dis. 2001, 56: 225-232.PubMed Glaspole IN, Wells AU, du Bois RM: Lung biopsy in diffuse parenchymal lung disease. Monaldi Arch Chest Dis. 2001, 56: 225-232.PubMed
4.
go back to reference American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000, 161: 646-664.CrossRef American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000, 161: 646-664.CrossRef
5.
go back to reference Flaherty KR, King TE, Raghu G, Lynch JP, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, Murray S, Lama VN, Gay SE, Martinez FJ: Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med. 2004, 170: 904-910. 10.1164/rccm.200402-147OC.PubMedCrossRef Flaherty KR, King TE, Raghu G, Lynch JP, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, Murray S, Lama VN, Gay SE, Martinez FJ: Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med. 2004, 170: 904-910. 10.1164/rccm.200402-147OC.PubMedCrossRef
6.
go back to reference Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD: The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest. 1999, 116: 1168-1174. 10.1378/chest.116.5.1168.PubMedCrossRef Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD: The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest. 1999, 116: 1168-1174. 10.1378/chest.116.5.1168.PubMedCrossRef
7.
go back to reference Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, Travis WD, Mumford JA, Murray S, Flint A, Lynch JP, Martinez FJ: Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003, 58: 143-148. 10.1136/thorax.58.2.143.PubMedPubMedCentralCrossRef Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, Travis WD, Mumford JA, Murray S, Flint A, Lynch JP, Martinez FJ: Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003, 58: 143-148. 10.1136/thorax.58.2.143.PubMedPubMedCentralCrossRef
8.
go back to reference Hunninghake GW, Zimmerman MB, Schwartz DA, King TE, Lynch J, Hegele R, Waldron J, Colby T, Muller N, Lynch D, Galvin J, Gross B, Hogg J, Toews G, Helmers R, Cooper JA, Baughman R, Strange C, Millard M: Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001, 164: 193-196. 10.1164/ajrccm.164.2.2101090.PubMedCrossRef Hunninghake GW, Zimmerman MB, Schwartz DA, King TE, Lynch J, Hegele R, Waldron J, Colby T, Muller N, Lynch D, Galvin J, Gross B, Hogg J, Toews G, Helmers R, Cooper JA, Baughman R, Strange C, Millard M: Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001, 164: 193-196. 10.1164/ajrccm.164.2.2101090.PubMedCrossRef
9.
go back to reference Lynch DA, Travis WD, Muller NL, Galvin JR, Hansell DM, Grenier PA, King TE: Idiopathic interstitial pneumonias: CT features. Radiology. 2005, 236: 10-21. 10.1148/radiol.2361031674.PubMedCrossRef Lynch DA, Travis WD, Muller NL, Galvin JR, Hansell DM, Grenier PA, King TE: Idiopathic interstitial pneumonias: CT features. Radiology. 2005, 236: 10-21. 10.1148/radiol.2361031674.PubMedCrossRef
10.
go back to reference Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE, Bradford WZ, Schwartz DA, Richard WW: High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005, 172: 488-493. 10.1164/rccm.200412-1756OC.PubMedCrossRef Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE, Bradford WZ, Schwartz DA, Richard WW: High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005, 172: 488-493. 10.1164/rccm.200412-1756OC.PubMedCrossRef
11.
go back to reference Mink SN, Maycher B: Comparative manifestations and diagnostic accuracy of high-resolution computed tomography in usual interstitial pneumonia and nonspecific interstitial pneumonia. Curr Opin Pulm Med. 2012, 18: 530-534. 10.1097/MCP.0b013e3283568026.PubMedCrossRef Mink SN, Maycher B: Comparative manifestations and diagnostic accuracy of high-resolution computed tomography in usual interstitial pneumonia and nonspecific interstitial pneumonia. Curr Opin Pulm Med. 2012, 18: 530-534. 10.1097/MCP.0b013e3283568026.PubMedCrossRef
12.
go back to reference Silva CI, Muller NL, Hansell DM, Lee KS, Nicholson AG, Wells AU: Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology. 2008, 247: 251-259. 10.1148/radiol.2471070369.PubMedCrossRef Silva CI, Muller NL, Hansell DM, Lee KS, Nicholson AG, Wells AU: Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology. 2008, 247: 251-259. 10.1148/radiol.2471070369.PubMedCrossRef
13.
go back to reference Sverzellati N, Wells AU, Tomassetti S, Desai SR, Copley SJ, Aziz ZA, Zompatori M, Chilosi M, Nicholson AG, Poletti V, Hansell DM: Biopsy-proved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology. 2010, 254: 957-964. 10.1148/radiol.0990898.PubMedCrossRef Sverzellati N, Wells AU, Tomassetti S, Desai SR, Copley SJ, Aziz ZA, Zompatori M, Chilosi M, Nicholson AG, Poletti V, Hansell DM: Biopsy-proved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology. 2010, 254: 957-964. 10.1148/radiol.0990898.PubMedCrossRef
14.
go back to reference Elliot TL, Lynch DA, Newell JD, Cool C, Tuder R, Markopoulou K, Veve R, Brown KK: High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J Comput Assist Tomogr. 2005, 29: 339-345. 10.1097/01.rct.0000162153.55253.d3.PubMedCrossRef Elliot TL, Lynch DA, Newell JD, Cool C, Tuder R, Markopoulou K, Veve R, Brown KK: High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J Comput Assist Tomogr. 2005, 29: 339-345. 10.1097/01.rct.0000162153.55253.d3.PubMedCrossRef
15.
go back to reference MacDonald SL, Rubens MB, Hansell DM, Copley SJ, Desai SR, du Bois RM, Nicholson AG, Colby TV, Wells AU: Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology. 2001, 221: 600-605. 10.1148/radiol.2213010158.PubMedCrossRef MacDonald SL, Rubens MB, Hansell DM, Copley SJ, Desai SR, du Bois RM, Nicholson AG, Colby TV, Wells AU: Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology. 2001, 221: 600-605. 10.1148/radiol.2213010158.PubMedCrossRef
16.
go back to reference Silva CI, Muller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, Chung MP, Churg A: Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008, 246: 288-297.PubMedCrossRef Silva CI, Muller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, Chung MP, Churg A: Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008, 246: 288-297.PubMedCrossRef
17.
go back to reference Fernandez Perez ER, Daniels CE, Schroeder DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES, Ryu JH: Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest. 2010, 137: 129-137. 10.1378/chest.09-1002.PubMedCrossRef Fernandez Perez ER, Daniels CE, Schroeder DR, St Sauver J, Hartman TE, Bartholmai BJ, Yi ES, Ryu JH: Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest. 2010, 137: 129-137. 10.1378/chest.09-1002.PubMedCrossRef
18.
go back to reference Hodgson U, Laitinen T, Tukiainen P: Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002, 57: 338-342. 10.1136/thorax.57.4.338.PubMedPubMedCentralCrossRef Hodgson U, Laitinen T, Tukiainen P: Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002, 57: 338-342. 10.1136/thorax.57.4.338.PubMedPubMedCentralCrossRef
19.
go back to reference Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, Latsi P, Polychronopoulos V, Birba G, Ch L, Bouros D: Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009, 103: 1122-1129. 10.1016/j.rmed.2009.03.001.PubMedCrossRef Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, Latsi P, Polychronopoulos V, Birba G, Ch L, Bouros D: Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009, 103: 1122-1129. 10.1016/j.rmed.2009.03.001.PubMedCrossRef
20.
go back to reference Thomeer M, Demedts M, Vandeurzen K: Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001, 56: 163-172.PubMedCrossRef Thomeer M, Demedts M, Vandeurzen K: Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001, 56: 163-172.PubMedCrossRef
21.
go back to reference Tinelli C, De Silvestri A, Richeldi L, Oggionni T: The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. Sarcoidosis Vasc Diffuse Lung Dis. 2005, 22 (Suppl 1): S4-S8.PubMed Tinelli C, De Silvestri A, Richeldi L, Oggionni T: The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report. Sarcoidosis Vasc Diffuse Lung Dis. 2005, 22 (Suppl 1): S4-S8.PubMed
22.
go back to reference Xaubet A, Ancochea J, Morell F, Rodriguez-Arias JM, Villena V, Blanquer R, Montero C, Sueiro A, Disdier C, Vendrell M: Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis. 2004, 21: 64-70.PubMed Xaubet A, Ancochea J, Morell F, Rodriguez-Arias JM, Villena V, Blanquer R, Montero C, Sueiro A, Disdier C, Vendrell M: Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis. 2004, 21: 64-70.PubMed
23.
go back to reference Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, Sato A, Kudoh S: Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005, 171: 1040-1047. 10.1164/rccm.200404-571OC.PubMedCrossRef Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, Taguchi Y, Nagai S, Itoh H, Ohi M, Sato A, Kudoh S: Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005, 171: 1040-1047. 10.1164/rccm.200404-571OC.PubMedCrossRef
24.
go back to reference Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM: Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011, 377: 1760-1769. 10.1016/S0140-6736(11)60405-4.PubMedCrossRef Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM: Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011, 377: 1760-1769. 10.1016/S0140-6736(11)60405-4.PubMedCrossRef
25.
go back to reference Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Takeuchi M, Raghu G, Kudoh S, Nukiwa T: Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2010, 35: 821-829. 10.1183/09031936.00005209.PubMedCrossRef Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Takeuchi M, Raghu G, Kudoh S, Nukiwa T: Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2010, 35: 821-829. 10.1183/09031936.00005209.PubMedCrossRef
26.
go back to reference Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M: High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005, 353: 2229-2242. 10.1056/NEJMoa042976.PubMedCrossRef Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M: High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005, 353: 2229-2242. 10.1056/NEJMoa042976.PubMedCrossRef
27.
go back to reference Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE: A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004, 350: 125-133. 10.1056/NEJMoa030511.PubMedCrossRef Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE: A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004, 350: 125-133. 10.1056/NEJMoa030511.PubMedCrossRef
28.
go back to reference Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR: Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. Am J Respir Crit Care Med. 2010, 181: 604-610. 10.1164/rccm.200906-0964OC.PubMedCrossRef Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR: Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. Am J Respir Crit Care Med. 2010, 181: 604-610. 10.1164/rccm.200906-0964OC.PubMedCrossRef
29.
go back to reference King TE, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stahler G, Leconte I, Roux S, Raghu G: BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2008, 177: 75-81. 10.1164/rccm.200705-732OC.PubMedCrossRef King TE, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stahler G, Leconte I, Roux S, Raghu G: BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2008, 177: 75-81. 10.1164/rccm.200705-732OC.PubMedCrossRef
30.
go back to reference King TE, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM: Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009, 374: 222-228. 10.1016/S0140-6736(09)60551-1.PubMedCrossRef King TE, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM: Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009, 374: 222-228. 10.1016/S0140-6736(09)60551-1.PubMedCrossRef
31.
go back to reference Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, Thomeer M, Utz JP, Khandker RK, McDermott L, Fatenejad S: Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med. 2008, 178: 948-955. 10.1164/rccm.200709-1446OC.PubMedCrossRef Raghu G, Brown KK, Costabel U, Cottin V, du Bois RM, Lasky JA, Thomeer M, Utz JP, Khandker RK, McDermott L, Fatenejad S: Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med. 2008, 178: 948-955. 10.1164/rccm.200709-1446OC.PubMedCrossRef
32.
go back to reference Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, Brun M, Gupta A, Juhel N, Kluglich M, du Bois RM: Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011, 365: 1079-1087. 10.1056/NEJMoa1103690.PubMedCrossRef Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, Brun M, Gupta A, Juhel N, Kluglich M, du Bois RM: Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011, 365: 1079-1087. 10.1056/NEJMoa1103690.PubMedCrossRef
33.
go back to reference Bensard DD, McIntyre RC, Waring BJ, Simon JS: Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest. 1993, 103: 765-770. 10.1378/chest.103.3.765.PubMedCrossRef Bensard DD, McIntyre RC, Waring BJ, Simon JS: Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest. 1993, 103: 765-770. 10.1378/chest.103.3.765.PubMedCrossRef
34.
go back to reference Ferson PF, Landreneau RJ, Dowling RD, Hazelrigg SR, Ritter P, Nunchuck S, Perrino MK, Bowers CM, Mack MJ, Magee MJ: Comparison of open versus thoracoscopic lung biopsy for diffuse infiltrative pulmonary disease. J Thorac Cardiovasc Surg. 1993, 106: 194-199.PubMed Ferson PF, Landreneau RJ, Dowling RD, Hazelrigg SR, Ritter P, Nunchuck S, Perrino MK, Bowers CM, Mack MJ, Magee MJ: Comparison of open versus thoracoscopic lung biopsy for diffuse infiltrative pulmonary disease. J Thorac Cardiovasc Surg. 1993, 106: 194-199.PubMed
35.
go back to reference Molin LJ, Steinberg JB, Lanza LA: VATS increases costs in patients undergoing lung biopsy for interstitial lung disease. Ann Thorac Surg. 1994, 58: 1595-1598. 10.1016/0003-4975(94)91638-1.PubMedCrossRef Molin LJ, Steinberg JB, Lanza LA: VATS increases costs in patients undergoing lung biopsy for interstitial lung disease. Ann Thorac Surg. 1994, 58: 1595-1598. 10.1016/0003-4975(94)91638-1.PubMedCrossRef
36.
go back to reference Rena O, Casadio C, Leo F, Giobbe R, Cianci R, Baldi S, Rapellino M, Maggi G: Videothoracoscopic lung biopsy in the diagnosis of interstitial lung disease. Eur J Cardiothorac Surg. 1999, 16: 624-627. 10.1016/S1010-7940(99)00320-6.PubMedCrossRef Rena O, Casadio C, Leo F, Giobbe R, Cianci R, Baldi S, Rapellino M, Maggi G: Videothoracoscopic lung biopsy in the diagnosis of interstitial lung disease. Eur J Cardiothorac Surg. 1999, 16: 624-627. 10.1016/S1010-7940(99)00320-6.PubMedCrossRef
37.
go back to reference Mouroux J, Clary-Meinesz C, Padovani B, Perrin C, Rotomondo C, Chavaillon JM, Blaive B, Richelme H: Efficacy and safety of videothoracoscopic lung biopsy in the diagnosis of interstitial lung disease. Eur J Cardiothorac Surg. 1997, 11: 22-26. 10.1016/S1010-7940(96)01007-X.PubMedCrossRef Mouroux J, Clary-Meinesz C, Padovani B, Perrin C, Rotomondo C, Chavaillon JM, Blaive B, Richelme H: Efficacy and safety of videothoracoscopic lung biopsy in the diagnosis of interstitial lung disease. Eur J Cardiothorac Surg. 1997, 11: 22-26. 10.1016/S1010-7940(96)01007-X.PubMedCrossRef
38.
go back to reference Miller JD, Urschel JD, Cox G, Olak J, Young JE, Kay JM, McDonald E: A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac Surg. 2000, 70: 1647-1650. 10.1016/S0003-4975(00)01913-5.PubMedCrossRef Miller JD, Urschel JD, Cox G, Olak J, Young JE, Kay JM, McDonald E: A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac Surg. 2000, 70: 1647-1650. 10.1016/S0003-4975(00)01913-5.PubMedCrossRef
39.
go back to reference Park JH, Kim DK, Kim DS, Koh Y, Lee SD, Kim WS, Kim WD, Park SI: Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. European Journal of Cardio-thoracic Surgery. 2007, 31: 1115-1119. 10.1016/j.ejcts.2007.02.035.PubMedCrossRef Park JH, Kim DK, Kim DS, Koh Y, Lee SD, Kim WS, Kim WD, Park SI: Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. European Journal of Cardio-thoracic Surgery. 2007, 31: 1115-1119. 10.1016/j.ejcts.2007.02.035.PubMedCrossRef
40.
go back to reference Sigurdsson MI, Isaksson HJ, Gudmundsson G, Gudbjartsson T: Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study. Ann Thorac Surg. 2009, 88: 227-232. 10.1016/j.athoracsur.2009.04.002.PubMedCrossRef Sigurdsson MI, Isaksson HJ, Gudmundsson G, Gudbjartsson T: Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study. Ann Thorac Surg. 2009, 88: 227-232. 10.1016/j.athoracsur.2009.04.002.PubMedCrossRef
41.
go back to reference Fibla JJ, Brunelli A, Cassivi SD, Deschamps C: Aggregate risk score for predicting mortality after surgical biopsy for interstitial lung disease. Interact Cardiovasc Thorac Surg. 2012, 15: 276-279. 10.1093/icvts/ivs174.PubMedPubMedCentralCrossRef Fibla JJ, Brunelli A, Cassivi SD, Deschamps C: Aggregate risk score for predicting mortality after surgical biopsy for interstitial lung disease. Interact Cardiovasc Thorac Surg. 2012, 15: 276-279. 10.1093/icvts/ivs174.PubMedPubMedCentralCrossRef
42.
43.
go back to reference Lettieri CJ, Veerappan GR, Helman DL, Mulligan CR, Shorr AF: Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest. 2005, 127: 1600-1605. 10.1378/chest.127.5.1600.PubMedCrossRef Lettieri CJ, Veerappan GR, Helman DL, Mulligan CR, Shorr AF: Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest. 2005, 127: 1600-1605. 10.1378/chest.127.5.1600.PubMedCrossRef
44.
go back to reference Tiitto L, Heiskanen U, Bloigu R, Paakko P, Kinnula V, Kaarteenaho-Wiik R: Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia. Chest. 2005, 128: 2375-2380. 10.1378/chest.128.4.2375.PubMedCrossRef Tiitto L, Heiskanen U, Bloigu R, Paakko P, Kinnula V, Kaarteenaho-Wiik R: Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia. Chest. 2005, 128: 2375-2380. 10.1378/chest.128.4.2375.PubMedCrossRef
45.
go back to reference Utz JP, Ryu JH, Douglas WW, Hartman TE, Tazelaar HD, Myers JL, Allen MS, Schroeder DR: High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J. 2001, 17: 175-179. 10.1183/09031936.01.17201750.PubMedCrossRef Utz JP, Ryu JH, Douglas WW, Hartman TE, Tazelaar HD, Myers JL, Allen MS, Schroeder DR: High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J. 2001, 17: 175-179. 10.1183/09031936.01.17201750.PubMedCrossRef
46.
go back to reference Pompeo E, Rogliani P, Cristino B, Schillaci O, Novelli G, Saltini C: Awake thoracoscopic biopsy of interstitial lung disease. Ann Thorac Surg. 2013, 95 (2): 445-52. 10.1016/j.athoracsur.2012.10.043.PubMedCrossRef Pompeo E, Rogliani P, Cristino B, Schillaci O, Novelli G, Saltini C: Awake thoracoscopic biopsy of interstitial lung disease. Ann Thorac Surg. 2013, 95 (2): 445-52. 10.1016/j.athoracsur.2012.10.043.PubMedCrossRef
47.
go back to reference Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU: The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002, 166: 173-177. 10.1164/rccm.2109039.PubMedCrossRef Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU: The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2002, 166: 173-177. 10.1164/rccm.2109039.PubMedCrossRef
48.
go back to reference Aziz ZA, Wells AU, Hansell DM, Bain GA, Copley SJ, Desai SR, Ellis SM, Gleeson FV, Grubnic S, Nicholson AG, Padley SP, Pointon KS, Reynolds JH, Robertson RJ, Rubens MB: HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax. 2004, 59: 506-511. 10.1136/thx.2003.020396.PubMedPubMedCentralCrossRef Aziz ZA, Wells AU, Hansell DM, Bain GA, Copley SJ, Desai SR, Ellis SM, Gleeson FV, Grubnic S, Nicholson AG, Padley SP, Pointon KS, Reynolds JH, Robertson RJ, Rubens MB: HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax. 2004, 59: 506-511. 10.1136/thx.2003.020396.PubMedPubMedCentralCrossRef
49.
go back to reference Peckham RM, Shorr AF, Helman DL: Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Respiration. 2004, 71: 165-169. 10.1159/000076678.PubMedCrossRef Peckham RM, Shorr AF, Helman DL: Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Respiration. 2004, 71: 165-169. 10.1159/000076678.PubMedCrossRef
50.
go back to reference Thomeer M, Demedts M, Behr J, Buhl R, Costabel U, Flower CD, Verschakelen J, Laurent F, Nicholson AG, Verbeken EK, Capron F, Sardina M, Corvasce G, Lankhorst I: Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J. 2008, 31: 585-591. 10.1183/09031936.00063706.PubMedCrossRef Thomeer M, Demedts M, Behr J, Buhl R, Costabel U, Flower CD, Verschakelen J, Laurent F, Nicholson AG, Verbeken EK, Capron F, Sardina M, Corvasce G, Lankhorst I: Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur Respir J. 2008, 31: 585-591. 10.1183/09031936.00063706.PubMedCrossRef
51.
go back to reference Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, Jain A, Strawderman RL, Flint A, Lynch JP, Martinez FJ: Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med. 2001, 164: 1722-1727. 10.1164/ajrccm.164.9.2103074.PubMedCrossRef Flaherty KR, Travis WD, Colby TV, Toews GB, Kazerooni EA, Gross BH, Jain A, Strawderman RL, Flint A, Lynch JP, Martinez FJ: Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med. 2001, 164: 1722-1727. 10.1164/ajrccm.164.9.2103074.PubMedCrossRef
52.
go back to reference Monaghan H, Wells AU, Colby TV, du Bois RM, Hansell DM, Nicholson AG: Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest. 2004, 125: 522-526. 10.1378/chest.125.2.522.PubMedCrossRef Monaghan H, Wells AU, Colby TV, du Bois RM, Hansell DM, Nicholson AG: Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest. 2004, 125: 522-526. 10.1378/chest.125.2.522.PubMedCrossRef
53.
go back to reference Travis WD, Hunninghake G, King TE, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, Flaherty KR, Franks TJ, Hansell DM, Hartman TE, Kazerooni EA, Kim DS, Kitaichi M, Koyama T, Martinez FJ, Nagai S, Midthun DE, Muller NL, Nicholson AG, Raghu G, Selman M, Wells A: Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008, 177: 1338-1347. 10.1164/rccm.200611-1685OC.PubMedCrossRef Travis WD, Hunninghake G, King TE, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, Flaherty KR, Franks TJ, Hansell DM, Hartman TE, Kazerooni EA, Kim DS, Kitaichi M, Koyama T, Martinez FJ, Nagai S, Midthun DE, Muller NL, Nicholson AG, Raghu G, Selman M, Wells A: Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008, 177: 1338-1347. 10.1164/rccm.200611-1685OC.PubMedCrossRef
54.
go back to reference Leslie KO, Cool CD, Sporn TA, Curran-Everett D, Steele MP, Brown KK, Wahidi MM, Schwartz DA: Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients. Arch Pathol Lab Med. 2012, 136: 1366-1376. 10.5858/arpa.2011-0627-OAI.PubMedCrossRef Leslie KO, Cool CD, Sporn TA, Curran-Everett D, Steele MP, Brown KK, Wahidi MM, Schwartz DA: Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients. Arch Pathol Lab Med. 2012, 136: 1366-1376. 10.5858/arpa.2011-0627-OAI.PubMedCrossRef
55.
go back to reference Enomoto N, Suda T, Kato M, Kaida Y, Nakamura Y, Imokawa S, Ida M, Chida K: Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest. 2006, 130: 22-29. 10.1378/chest.130.1.22.PubMedCrossRef Enomoto N, Suda T, Kato M, Kaida Y, Nakamura Y, Imokawa S, Ida M, Chida K: Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest. 2006, 130: 22-29. 10.1378/chest.130.1.22.PubMedCrossRef
56.
go back to reference King TE, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA, Flint A, Thurlbeck W, Cherniack RM: Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001, 164: 1025-1032. 10.1164/ajrccm.164.6.2001056.PubMedCrossRef King TE, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA, Flint A, Thurlbeck W, Cherniack RM: Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001, 164: 1025-1032. 10.1164/ajrccm.164.6.2001056.PubMedCrossRef
57.
go back to reference Lee SH, Shim HS, Cho SH, Kim SY, Lee SK, Son JY, Jung JY, Kim EY, Lim JE, Lee KJ, Park BH, Kang YA, Kim YS, Kim SK, Chang J, Park MS: Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects. Sarcoidosis Vasc Diffuse Lung Dis. 2011, 28: 102-112.PubMed Lee SH, Shim HS, Cho SH, Kim SY, Lee SK, Son JY, Jung JY, Kim EY, Lim JE, Lee KJ, Park BH, Kang YA, Kim YS, Kim SK, Chang J, Park MS: Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects. Sarcoidosis Vasc Diffuse Lung Dis. 2011, 28: 102-112.PubMed
58.
go back to reference Tiitto L, Bloigu R, Heiskanen U, Pääkkö P, Kinnula VL, Kaarteenaho-Wiik R: Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia. Thorax. 2006, 61: 1091-1095. 10.1136/thx.2005.055814.PubMedPubMedCentralCrossRef Tiitto L, Bloigu R, Heiskanen U, Pääkkö P, Kinnula VL, Kaarteenaho-Wiik R: Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia. Thorax. 2006, 61: 1091-1095. 10.1136/thx.2005.055814.PubMedPubMedCentralCrossRef
59.
go back to reference Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, Thannickal VJ, Kazerooni EA, Gross BH, Lynch JP, Martinez FJ: Fibroblast foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med. 2003, 167 (10): 1410-5. 10.1164/rccm.200204-373OC.PubMedCrossRef Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, Thannickal VJ, Kazerooni EA, Gross BH, Lynch JP, Martinez FJ: Fibroblast foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med. 2003, 167 (10): 1410-5. 10.1164/rccm.200204-373OC.PubMedCrossRef
60.
go back to reference Hanak V: Ryu JH, de CE, Limper AH, Hartman TE, Decker PA, Myers JL: Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. Respir Med. 2008, 102: 852-856. 10.1016/j.rmed.2008.01.012.PubMedCrossRef Hanak V: Ryu JH, de CE, Limper AH, Hartman TE, Decker PA, Myers JL: Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. Respir Med. 2008, 102: 852-856. 10.1016/j.rmed.2008.01.012.PubMedCrossRef
61.
go back to reference Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Pääkkö P: Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med. 1996, 154: 511-518. 10.1164/ajrccm.154.2.8756830.PubMedCrossRef Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Pääkkö P: Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med. 1996, 154: 511-518. 10.1164/ajrccm.154.2.8756830.PubMedCrossRef
62.
go back to reference Berbescu EA, Katzenstein AL, Snow JL, Zisman DA: Transbronchial biopsy in usual interstitial pneumonia. Chest. 2006, 129: 1126-1131. 10.1378/chest.129.5.1126.PubMedPubMedCentralCrossRef Berbescu EA, Katzenstein AL, Snow JL, Zisman DA: Transbronchial biopsy in usual interstitial pneumonia. Chest. 2006, 129: 1126-1131. 10.1378/chest.129.5.1126.PubMedPubMedCentralCrossRef
63.
go back to reference Tomassetti S, Cavazza A, Colby TV, Ryu JH, Nanni O, Scarpi E, Tantalocco P, Buccioli M, Dubini A, Piciucchi S, Ravaglia C, Gurioli C, Casoni GL, Gurioli C, Romagnoli M, Poletti V: Transbronchial biopsy is useful in predicting UIP pattern. Respir Res. 2012, 13: 96-10.1186/1465-9921-13-96.PubMedPubMedCentralCrossRef Tomassetti S, Cavazza A, Colby TV, Ryu JH, Nanni O, Scarpi E, Tantalocco P, Buccioli M, Dubini A, Piciucchi S, Ravaglia C, Gurioli C, Casoni GL, Gurioli C, Romagnoli M, Poletti V: Transbronchial biopsy is useful in predicting UIP pattern. Respir Res. 2012, 13: 96-10.1186/1465-9921-13-96.PubMedPubMedCentralCrossRef
64.
go back to reference Shim HS, Park MS, Park IK: Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia. Pathol Int. 2010, 60: 373-377. 10.1111/j.1440-1827.2010.02528.x.PubMedCrossRef Shim HS, Park MS, Park IK: Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia. Pathol Int. 2010, 60: 373-377. 10.1111/j.1440-1827.2010.02528.x.PubMedCrossRef
65.
go back to reference Katzenstein AL: Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod Pathol. 2012, 25 (Suppl 1): S68-S78.PubMedCrossRef Katzenstein AL: Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod Pathol. 2012, 25 (Suppl 1): S68-S78.PubMedCrossRef
66.
go back to reference Babiak A, Hetzel J, Krishna G, Fritz P, Moeller P, Balli T, Hetzel M: Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration. 2009, 78: 203-208. 10.1159/000203987.PubMedCrossRef Babiak A, Hetzel J, Krishna G, Fritz P, Moeller P, Balli T, Hetzel M: Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration. 2009, 78: 203-208. 10.1159/000203987.PubMedCrossRef
67.
go back to reference Casoni GL, Cavazza A, Dubini A, Tomassetti S, Romagnoli M, Ravaglia C, Gurioli C, Pietrangeli C, Poletti V: Identification of the pathological pattern by transbronchial lung cryobiopsies in patients with fibrosing diffuse parenchymal lung disease. Eur Respir J. 2012, 40 (Suppl 56): 512-Abstract Casoni GL, Cavazza A, Dubini A, Tomassetti S, Romagnoli M, Ravaglia C, Gurioli C, Pietrangeli C, Poletti V: Identification of the pathological pattern by transbronchial lung cryobiopsies in patients with fibrosing diffuse parenchymal lung disease. Eur Respir J. 2012, 40 (Suppl 56): 512-Abstract
68.
go back to reference Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ: Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012, 366: 1968-1977.PubMedCrossRef Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ: Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012, 366: 1968-1977.PubMedCrossRef
69.
go back to reference Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B: An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012, 185: 1004-1014. 10.1164/rccm.201202-0320ST.PubMedCrossRef Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B: An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012, 185: 1004-1014. 10.1164/rccm.201202-0320ST.PubMedCrossRef
70.
go back to reference Karvonen HM, Lehtonen ST, Sormunen RT, Harju TH, Lappi-Blanco E, Bloigu RS, Kaarteenaho RL: Myofibroblasts in interstitial lung diseases show diverse electron microscopic and invasive features. Lab Invest. 2012, 92: 1270-1284. 10.1038/labinvest.2012.95.PubMedCrossRef Karvonen HM, Lehtonen ST, Sormunen RT, Harju TH, Lappi-Blanco E, Bloigu RS, Kaarteenaho RL: Myofibroblasts in interstitial lung diseases show diverse electron microscopic and invasive features. Lab Invest. 2012, 92: 1270-1284. 10.1038/labinvest.2012.95.PubMedCrossRef
71.
go back to reference Larsen BT, Colby TV: Update for pathologists on idiopathic interstitial pneumonias. Arch Pathol Lab Med. 2012, 136: 1234-1241. 10.5858/arpa.2012-0225-RA.PubMedCrossRef Larsen BT, Colby TV: Update for pathologists on idiopathic interstitial pneumonias. Arch Pathol Lab Med. 2012, 136: 1234-1241. 10.5858/arpa.2012-0225-RA.PubMedCrossRef
72.
go back to reference Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR: Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2012, Dec 6. (epub ahead of print) Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR: Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2012, Dec 6. (epub ahead of print)
Metadata
Title
The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis
Author
Riitta Kaarteenaho
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2013
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-14-43

Other articles of this Issue 1/2013

Respiratory Research 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine